GRAIL, Inc. funding
GRAIL, Inc., a biotechnology company based in Menlo Park, CA, filed a Form D with the SEC on November 7, 2025 and reported $325M raised.
Amount raised$325M
Offering size$325M
Filed with the SECNovember 7, 2025
First saleOctober 21, 2025
IndustryBiotechnology
SecuritiesEquity, Options or warrants, Security to be acquired on exercise
LocationMenlo Park, CA
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far17
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Nov 7
Other health care rounds in California
Alpfa Medical, Inc.$80.3M · Sep 28Other Health CareBigHat Biosciences, Inc.$75.1M · Oct 26BiotechnologyCaspian Therapeutics, Inc.$50M · Sep 23BiotechnologyEstuary Biotherapeutics, Inc.$40.7M · Oct 16BiotechnologyPFARADIGM Health, Inc.$31.1M · Sep 28Other Health CareTrellis Bioscience, Inc.$22.9M · Oct 21BiotechnologyAltay Therapeutics, Inc.$15.7M · Oct 2BiotechnologyAdela, Inc.$12M · Oct 19Biotechnology